These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36945210)

  • 1. Tumor grade 2 as the independent predictor for lymph node metastasis in 10-20 mm sized rectal neuroendocrine tumor.
    Park BS; Cho SH; Son GM; Kim HS; Kim SJ; Park SB; Choi CW; Kim HW; Shin DH
    Korean J Clin Oncol; 2021 Jun; 17(1):37-43. PubMed ID: 36945210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of lymph node metastasis after endoscopic treatment for rectal NETs 10 mm or less.
    Inada Y; Yoshida N; Fukumoto K; Hirose R; Inoue K; Dohi O; Murakami T; Ogiso K; Tomie A; Kugai M; Yoriki H; Inagaki Y; Hasegawa D; Okuda K; Okuda T; Morinaga Y; Kishimoto M; Itoh Y
    Int J Colorectal Dis; 2021 Mar; 36(3):559-567. PubMed ID: 33388960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data.
    Wang Y; Zhang Y; Lin H; Xu M; Zhou X; Zhuang J; Yang Y; Chen B; Liu X; Guan G
    J Surg Oncol; 2021 Dec; 124(7):1098-1105. PubMed ID: 34291822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of atypical endoscopic features in rectal neuroendocrine tumors.
    Hyun JH; Lee SD; Youk EG; Lee JB; Lee EJ; Chang HJ; Sohn DK
    World J Gastroenterol; 2015 Dec; 21(47):13302-8. PubMed ID: 26715813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel risk-scoring system for predicting lymph node metastasis of rectal neuroendocrine tumors.
    Chida K; Watanabe J; Hirasawa K; Inayama Y; Misumi T; Kunisaki C; Endo I
    Ann Gastroenterol Surg; 2020 Sep; 4(5):562-570. PubMed ID: 33005851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
    Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
    Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of treatment for rectal neuroendocrine tumors sized under 20 mm in comparison with the WHO 2010 guidelines.
    Matsuhashi N; Takahashi T; Tomita H; Araki H; Ibuka T; Tanaka K; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Yamaguchi K; Osada S; Yoshida K
    Mol Clin Oncol; 2017 Sep; 7(3):476-480. PubMed ID: 28894583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Lymph Node Metastasis and Survival Outcomes in Colorectal Neuroendocrine Tumors.
    Wu Z; Wang Z; Zheng Z; Bi J; Wang X; Feng Q
    Cancer Manag Res; 2020; 12():7151-7164. PubMed ID: 32848469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis.
    Kang HS; Kwon MJ; Kim TH; Han J; Ju YS
    Pathol Res Pract; 2019 Nov; 215(11):152642. PubMed ID: 31585816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.
    Zhou YJ; Wang QW; Zhang QW; Chen JN; Wang XY; Gao YJ; Li XB
    Front Endocrinol (Lausanne); 2021; 12():658392. PubMed ID: 34122337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
    Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
    Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion.
    Nam SJ; Kim BC; Chang HJ; Jeon HH; Kim J; Kim SY
    Gut Liver; 2022 Mar; 16(2):228-235. PubMed ID: 34552040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Factors Predicting Lymph Node Metastasis Between pT1 Rectal Cancer and pT1 Colon Cancer: A Retrospective Study.
    Cho SH; Park BS; Son GM; Kim HS; Kim SJ; Park SB; Choi CW; Kim HW; Shin DH; Yun MS
    Am Surg; 2023 Dec; 89(12):5829-5836. PubMed ID: 35766839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis.
    Brunner W; Widmann B; Marti L; Tarantino I; Schmied BM; Warschkow R
    Surg Endosc; 2016 Oct; 30(10):4405-15. PubMed ID: 26895892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors.
    Jiang Y; Jin JB; Zhan Q; Deng XX; Shen BY
    Chin Med J (Engl); 2015 Dec; 128(24):3335-44. PubMed ID: 26668149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural course of an untreated metastatic perirectal lymph node after the endoscopic resection of a rectal neuroendocrine tumor.
    Kim SH; Yang DH; Lee JS; Park S; Lee HS; Lee H; Park SH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH; Kim CW; Kim J
    Intest Res; 2015 Apr; 13(2):175-9. PubMed ID: 25932004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for lymph node metastasis in T1 colorectal cancer.
    Suh JH; Han KS; Kim BC; Hong CW; Sohn DK; Chang HJ; Kim MJ; Park SC; Park JW; Choi HS; Oh JH
    Endoscopy; 2012 Jun; 44(6):590-5. PubMed ID: 22638780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
    Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
    J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of lymph node metastasis in pancreatic neuroendocrine tumor.
    Taki K; Hashimoto D; Nakagawa S; Ozaki N; Tomiyasu S; Ohmuraya M; Arima K; Kaida T; Higashi T; Sakamoto K; Sakata K; Okabe H; Nitta H; Hayashi H; Chikamoto A; Beppu T; Takamori H; Hirota M; Baba H
    Surg Today; 2017 Sep; 47(9):1104-1110. PubMed ID: 28229300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors.
    Zhang Z; Wang F; Li Z; Ye Z; Zhuo Q; Xu W; Liu W; Liu M; Fan G; Qin Y; Zhang Y; Chen X; Yu X; Xu X; Ji S
    BMC Surg; 2022 May; 22(1):160. PubMed ID: 35538535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.